< Back to all Breaking News
RHHBY, IMGN
12/19/2014 05:12am
ImmunoGen reports Phase III MARIANNE study met non-inferiority endpoint 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
